J. Gillen

Platelet factor 4–induced T _H 1-T _reg polarization suppresses antitumor immunity

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth

Therapeutic targeting of the angiopoietin–TIE pathway

Drivers of green supply chain management: a close-up study

VEGF in Signaling and Disease: Beyond Discovery and Development

Therapeutic Targeting of the Tumor Microenvironment

Role of green innovation and supply chain management in driving sustainable corporate performance

Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma

Angiopoietin-1 and Angiopoietin-2 Inhibitors: Clinical Development